Comparing of PDS Biotechnology Corporation (PDSB) and Flex Pharma Inc. (NASDAQ:FLKS)

PDS Biotechnology Corporation (NASDAQ:PDSB) and Flex Pharma Inc. (NASDAQ:FLKS), are influenced by compare since they are both players in the Biotechnology. These factors are particularly influence the profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation of the two firms.

Earnings & Valuation

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
PDS Biotechnology Corporation N/A 0.00 4.64M -26.25 0.00
Flex Pharma Inc. N/A 12.70 15.93M -1.22 0.00

Demonstrates PDS Biotechnology Corporation and Flex Pharma Inc. earnings per share (EPS), top-line revenue and valuation.

Profitability

Table 2 has PDS Biotechnology Corporation and Flex Pharma Inc.’s return on equity, net margins and return on assets.

Net Margins Return on Equity Return on Assets
PDS Biotechnology Corporation 0.00% -118.1% -82.7%
Flex Pharma Inc. 0.00% -155.3% -128.1%

Volatility & Risk

A beta of 3.31 shows that PDS Biotechnology Corporation is 231.00% more volatile than Standard and Poor’s 500. Flex Pharma Inc.’s 1.77 beta is the reason why it is 77.00% more volatile than Standard and Poor’s 500.

Liquidity

5.6 and 5.6 are the respective Current Ratio and a Quick Ratio of PDS Biotechnology Corporation. Its rival Flex Pharma Inc.’s Current and Quick Ratios are 8.9 and 8.8 respectively. Flex Pharma Inc. has a better chance of clearing its pay short and long-term debts than PDS Biotechnology Corporation.

Insider and Institutional Ownership

PDS Biotechnology Corporation and Flex Pharma Inc. has shares owned by institutional investors as follows: 27.5% and 13.7%. Insiders owned 6.5% of PDS Biotechnology Corporation shares. On the other hand, insiders owned about 16.9% of Flex Pharma Inc.’s shares.

Performance

In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
PDS Biotechnology Corporation 28.59% 36.69% 5.6% -38% -57.03% 35.2%
Flex Pharma Inc. -0.96% -35.72% 25.3% -22.03% -89.28% 21.58%

For the past year PDS Biotechnology Corporation’s stock price has bigger growth than Flex Pharma Inc.

Summary

PDS Biotechnology Corporation beats Flex Pharma Inc. on 4 of the 7 factors.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.